A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

November 14, 2008

Small Study Fingers 'Silent' Heart Disease in HIV-Positive Men

A team of French researchers recommends regular cardiovascular disease checkups for people on antiretroviral (ARV) therapy, even if they don’t have a history or obvious symptoms of heart problems. This suggestion stems from new study results, published in the November 30 issue of AIDS, indicating higher-than-expected rates of “silent” heart problems and exercise intolerance in a group of otherwise healthy HIV-positive men.

Gilles Thöni, from Avignon University in France, and his colleagues reported not long ago that a group of their adult HIV-positive patients had reduced exercise tolerance—a decrease in the heart’s ability to pump oxygen-saturated blood during strenuous aerobic activity. To investigate this further, Thöni’s group enrolled 16 HIV-positive men between the ages of 30 and 50; none were obese or had histories or symptoms of cardiovascular disease. All of the men were on ARV therapy, with an average CD4 count of 504 cells. They were compared with a group of 21 HIV-negative men who were similar in terms of age, smoking and health factors other than HIV.

Upon conducting echocardiograms of the heart while the men were resting, researchers found that several of the HIV-positive study volunteers had problems with the left ventricle—one of the heart’s four chambers. Not one of the HIV-negative men had this problem. 

During exercise, the HIV-positive men were more likely to experience heart output problems (increased difficulty pumping oxygenated blood) and muscular exhaustion (a decrease in oxygen reaching the body’s tissues) compared with the HIV-negative study volunteers.

Although the study was small, Thöni’s team found the results significant enough to recommend regular cardiac testing for HIV-positive individuals. Options include echocardiograms, electrocardiograms and exercise testing. According to the study authors, they should not be limited to those with histories or symptoms of cardiovascular disease.

Search: heart, cardiovascular, ischemia, echocardiogram, electrocardiogram, ECG, EKG, exercise, Gilles Thöni


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 1 (of 1 total)    

john, seattle, 2008-11-27 02:36:55
wow what a suprise i am on my 6th heart stent. my first M.I. was shortly after i started taking norvir in 2000

comments 1 - 1 (of 1 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    acousticmat
    Oakland
    California


    guycmh328
    Columbus
    Ohio


    gustavthesolid
    New York
    New York


    thebake
    Sioux Falls
    South Dakota
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.